Atomic-Level Structures Reveal How a Repurposed 3‑Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase
Priyanka Gade, Karolina Michalska, Jan Zitko, Jacek Wower, Natalia Maltseva, Vinod Sukanth Kumar Pallabothula, Robert Jedrzejczak, Andrzej Joachimiak · 2026
Read Atomic-Level Structures Reveal How a Repurposed 3‑Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase by Priyanka Gade, Karolina Michalska, Jan Zitko, Jacek Wower, Natalia Maltseva, Vinod Sukanth Kumar Pallabothula, Robert Jedrzejczak, Andrzej Joachimiak (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13629369.txt.
Description
Priyanka Gade and co-authors present a study the catalog lists under 2026. Tuberculosis is again the top killer among single infectious agents worldwide. Protein-building enzymes in the germ are promising drug targets. Human and bacterial versions differ enough to aim at. The team repurposed a scaffold first built against the human enzyme. Their target is the germ's prolyl-tRNA synthetase, which loads one amino acid for protein building.
The new compounds hit drug-resistant germ strains hard and spare human liver cells in tests. Crystal structures show six variants bound inside the enzyme. They sit in the energy pocket and warp the proline pocket, a dual-site grip. TB drug teams get a structural blueprint for the next design round. Atomic detail turns guesswork into targeted chemistry against a pathogen that badly needs new drugs.
Catalog record
| CREATOR | Priyanka Gade, Karolina Michalska, Jan Zitko, Jacek Wower, Natalia Maltseva, Vinod Sukanth Kumar Pallabothula, Robert Jedrzejczak, Andrzej Joachimiak |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |